Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myrbetriq and Brown Adipose Tissue Activation
NCT01783470Phase 2Completed
- Start
- Feb 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mirabegron in obesity. Started Feb 2013; status: completed.
02
Drugs
mirabegron
03
Conditions
obesity
Beyond the preview
Go deeper on NCT01783470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783470.